Valeria Pozzilli

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors.

Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 17, 2026

Targeting shared immune pathways in multiple sclerosis and type 1 diabetes: Therapeutic insights from monoclonal antibodies.

Targeting shared immune pathways in multiple sclerosis and type 1 diabetes: Therapeutic insights from monoclonal antibodies.

Journal: Autoimmunity reviews

Published: March 26, 2026

Chronic Active Lesions in Pediatric Multiple Sclerosis-Reply.

Chronic Active Lesions in Pediatric Multiple Sclerosis-Reply.

Journal: JAMA neurology

Published: March 23, 2026

GLP-1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials.

GLP-1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials.

Journal: Journal of neuroendocrinology

Published: March 06, 2026

Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials.

Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 23, 2026

Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy.

Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: November 03, 2025

Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profile.

Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profile.

Journal: BMJ open

Published: September 25, 2025

Slowly Expanding Lesions in Pediatric-Onset Multiple Sclerosis.

Slowly Expanding Lesions in Pediatric-Onset Multiple Sclerosis.

Journal: JAMA neurology

Published: August 11, 2025

The postdoc paradox: a career without a path.

The postdoc paradox: a career without a path.

Journal: Brain : a journal of neurology

Published: June 30, 2025

CSF IL-6 in children with neuroinflammatory conditions.

CSF IL-6 in children with neuroinflammatory conditions.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: June 13, 2025

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Journal: Neurology and therapy

Published: May 25, 2025

Epilepsy in MS and its association with cognitive and psychological burden.

Epilepsy in MS and its association with cognitive and psychological burden.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: March 18, 2025

Showing 1-12 of 37

Last Updated: 09/26/2026